Sprout investors say Valeant prices ?female Viagra? too high: Bloomberg
 

Sprout investors say Valeant prices ?female Viagra? too high: Bloomberg
(Reuters) - Investors in Sprout Pharmaceuticals, which makes the first drug to treat low ***ual desire in women and was bought by Valeant Pharmaceuticals International Inc last year, say the drug has been priced too high, Bloomberg reported on Friday.


http://rc.feedsportal.com/r/24739598...24/rc/1/rc.img

http://rc.feedsportal.com/r/24739598...24/rc/2/rc.img

http://rc.feedsportal.com/r/24739598...24/rc/3/rc.img

http://da.feedsportal.com/r/24739598...0/sc/24/a2.img
http://adchoice.feedsportal.com/r/24.../sc/24/ach.imghttp://pi.feedsportal.com/r/24739598.../sc/24/a2t.imghttp://pi2.feedsportal.com/r/2473959...sc/24/a2t2.imghttp://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...6Y:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...6Y:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/woppzDGS4ac